ACAT1 was found to be upregulated in doxorubicin-resistant uterine cancer, and its knockdown correlated with inhibited migration and proliferation of cancer cells, as well as enhanced apoptosis 27. The gene discussed is ACAT1; the disease is uterine cancer.